Compound ID | 1807
Actinocarbasin
Class: Lipoglycopeptide (arilomycin)
| Spectrum of activity: | Gram-positive |
| Details of activity: | Inhibits the signal peptidase of Staphylococcus type IB (Spase) |
| Combined with other compounds: | Yes |
| Description: | Natural compound |
| Institute where first reported: | Merck |
| Year first mentioned: | 2012 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive (as of 2022) |
| External links: | |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.